17-alpha-hydroxyprogesterone has been researched along with Birth Weight in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (15.91) | 18.7374 |
1990's | 2 (4.55) | 18.2507 |
2000's | 12 (27.27) | 29.6817 |
2010's | 21 (47.73) | 24.3611 |
2020's | 2 (4.55) | 2.80 |
Authors | Studies |
---|---|
Choi, YJ; Kim, B; Kim, MS; Woo, S; Yoon, YA | 1 |
Albert, BB; de Hora, MR; Heather, NL; Hofman, PL; Webster, D | 1 |
Anandi, VS; Shaila, B | 1 |
Calderón-Rojas, AL; Contreras-García, GA; Díaz-Martínez, LA; Gómez-Tarazona, CA; Mantilla-Mora, G; Martínez-Paredes, JF; Mendoza-Rojas, VC; Mora-Bautista, VM; Pinzón-Mantilla, K | 1 |
Almenares, P; Arteaga, AL; Carvajal, F; Castells, EM; Coto, R; Del Río, L; Espinosa, T; Fernández, JL; Frómeta, A; González, EC; Pérez, PL; Robaina, R; Segura, MT; Tejeda, Y | 1 |
Chakraborty, P; Ducharme, R; Hawken, S; Little, J; Potter, BK; Thébaud, B; Wilson, K | 1 |
Cruz Ortiz, SG; Llorens, A; Pereira, OM; Rosa, ER | 1 |
Hijikata, A; Kashimada, K; Katsumata, N; Matsubara, Y; Mizutani, S; Morio, T; Ohara, O; Ono, M; Takagi, M; Takasawa, K | 1 |
Campos, Td; Cechinel, E; Cristiano, AN; Lee, Jv; Linhares, RM; Nascimento, ML; Ohira, M; Silva, PC; Simoni, G | 1 |
Chen, Y; Jiang, D; Wang, B; Zhang, Q | 1 |
Martin, SE; Miras, MB; Muñoz, LN; Ochetti, M; Perez, G; Silvano, LK; Sobrero, GM; Testa, GM | 1 |
Chakraborty, P; Ducharme, R; Hawken, S; Little, J; Potter, BK; Walker, M; Wilson, K | 1 |
Berberich, SL; Dagle, JM; Ryckman, KK | 1 |
Anazawa, A; Hasegawa, S; Kashimada, K; Kitagawa, T; Konishi, K; Morio, T; Onishi, T; Ono, M; Tsuji, A | 1 |
Bachega, TA; Brito, VN; Carvalho, DF; de Miranda, MC; Faure, C; Hayashi, GY; Madureira, G; Mendonca, BB; Rodrigues, AS; Vallejos, C | 1 |
Choi, JW; Jun, YH; Lee, JE; Lee, MH; Moon, Y; Oh, KI | 1 |
Anderson, H; Dunaif, A; Fogel, N; Grebe, SK; Singh, RJ; Taylor, RL | 1 |
Heinonen, K; Nykänen, P; Riepe, FG; Sippell, WG; Voutilainen, R | 1 |
Akinbi, HT; Chandrasekar, R; Leslie, ND; Linard, SM; Meinzen-Derr, J; Rose, SR; Slaughter, JL | 1 |
Bachega, TA; Brito, VN; Brondi, MF; Faure, C; Hayashi, G; Mendonca, BB; Oliveira, E; Soares, D; Vallejos, C | 1 |
Barat, P; Brossaud, J; Corcuff, JB; Fagour, L | 1 |
Berberich, SL; Berends, SK; Busch, T; Cook, DE; Dagle, JM; Murray, JC; Ryckman, KK; Shchelochkov, OA | 1 |
Baş, F; Bundak, R; Darendeliler, F; Günöz, H; Saka, N; Uçar, A | 1 |
Levitsky, LL; Misra, M; Sola Pou, J; von Oettingen, J | 1 |
Bolt, RJ; Delemarre-van de Waal, HA; Lafeber, HN; Popp-Snijders, C; Sweep, FG; Van Weissenbruch, MM | 1 |
Fingerhut, R; Liebl, B; Olgemöller, B; Roscher, AA | 1 |
Beringue, F; Berthelot, J; Bonneau, D; Coutant, R; Descamps, P; Gatelais, F; Limal, JM | 1 |
Elvers, BH; Otten, BJ; Oudshoorn, CG; van Baarle, M; van der Kamp, HJ; Verkerk, PH; Wit, JM | 1 |
de Zegher, F; Ibáñez, L; Jiménez, R | 1 |
Bartoshesky, L; Mackley, A; Pau, DA | 1 |
Andeasen, HR; Axelstad, M; Boberg, J; Dalgaard, M; Hass, U; Taxvig, C; Vinggaard, AM | 1 |
Cabré, S; Callejo, J; de Zegher, F; Dunger, D; Ibáñez, L; López-Bermejo, A; Torres, A | 1 |
Balsamo, A; Bernardi, F; Cacciari, E; Capelli, M; Cassio, A; Cicognani, A; Piazzi, S; Pirazzoli, P; Salardi, S; Zappulla, F | 2 |
Dyas, J; Hughes, IA; Joyce, BG; Murphy, JF | 1 |
de Zegher, F; Ibáñez, L; Potau, N | 1 |
Barzilai, A; Davidovitch, N; Kogan, A; Kuint, J; Linder, N; Mazkeret, R; Sack, J | 1 |
Azócar, M; Cattani, A; Foradori, A; Poggi, H; Reyes, ML; Romeo, E; Soto, J; Valdivia, L | 1 |
Bengolea, S; Bergadá, C; Bossi, G; Chiesa, A; Gruñeiro-Papendieck, L; Prieto, L | 1 |
Bolt, RJ; Delemarre-van de Waal, HA; Lafeber, HN; Popp-Snijders, C; Sweep, CG; van Weissenbruch, MM | 1 |
Berg, GJ; Lee, MM; Moshang, T; Rajagopalan, L | 1 |
Kitagawa, T; Matsumoto, M; Murata, M; Okada, K; Shimozawa, K; Tsuchiya, Y | 1 |
Beesley, J; Giles, CA; Ross, AM; Taylor, NF; Thomson, M; Wallace, AM | 1 |
Apelman, Z; Borenstein, R; Dreazen, E; Kessler, I; Lancet, M; Mogilner, BM; Yemini, M | 1 |
1 trial(s) available for 17-alpha-hydroxyprogesterone and Birth Weight
Article | Year |
---|---|
Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Birth Weight; Double-Blind Method; Female; Humans; Hydroxyprogesterones; Infant Mortality; Infant, Newborn; Infant, Premature; Obstetric Labor, Premature; Pregnancy; Random Allocation | 1985 |
43 other study(ies) available for 17-alpha-hydroxyprogesterone and Birth Weight
Article | Year |
---|---|
Establishing 17-Hydroxyprogesterone Cutoff Values for Congenital Adrenal Hyperplasia in Preterm, Low Birth Weight, and Sick Newborns.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Humans; Infant, Low Birth Weight; Infant, Newborn; Neonatal Screening | 2023 |
Birth Weight- or Gestational Age-adjusted Second-tier LCMSMS Cutoffs Improve Newborn Screening for CAH in New Zealand.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Chromatography, High Pressure Liquid; False Negative Reactions; False Positive Reactions; Female; Gestational Age; Humans; Infant, Newborn; Male; Neonatal Screening; New Zealand; Predictive Value of Tests; Reference Values; Steroids; Tandem Mass Spectrometry | 2021 |
Evaluation of factors associated with elevated newborn 17-hydroxyprogesterone levels.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Asphyxia; Biomarkers; Birth Weight; Female; Follow-Up Studies; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Male; Neonatal Screening; Pregnancy; Prognosis; Retrospective Studies; Risk Factors; Seizures; Sepsis | 2017 |
17-hydroxiprogesterone values in healthy preterm infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Cohort Studies; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Longitudinal Studies; Male; Neonatal Screening | 2017 |
Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Cuba; Dried Blood Spot Testing; Early Diagnosis; Female; Gestational Age; Humans; Incidence; Infant; Infant, Newborn; Male; Neonatal Screening | 2013 |
Metabolomics of prematurity: analysis of patterns of amino acids, enzymes, and endocrine markers by categories of gestational age.
Topics: 17-alpha-Hydroxyprogesterone; Amino Acids; Arginine; Birth Weight; Cohort Studies; Endocrine System; Enzymes; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Leucine; Male; Metabolome; Neonatal Screening; Ontario; Premature Birth; Thyrotropin-Releasing Hormone; Time Factors; Valine | 2014 |
Pregnancy and neonatal outcomes of women receiving compounded 17-alpha hydroxyprogesterone at San Juan City hospital.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Birth Weight; Drug Evaluation; Female; Gestational Age; Home Care Services, Hospital-Based; Humans; Infant, Newborn; Infant, Premature; Injections, Intramuscular; Male; Obstetric Labor, Premature; Pregnancy; Pregnancy Outcome; Premature Birth; Puerto Rico; Recurrence; Stillbirth; Tocolytic Agents; Urban Population | 2013 |
Two novel HSD3B2 missense mutations with diverse residual enzymatic activities for Δ5-steroids.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Amino Acid Sequence; Birth Weight; DNA Mutational Analysis; Female; Humans; Infant, Newborn; Molecular Sequence Data; Mutation; Mutation, Missense; Neonatal Screening; Progesterone Reductase; Protein Binding; Protein Structure, Tertiary; Sequence Homology, Amino Acid | 2014 |
Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Animals; Birth Weight; Brazil; Female; Heel; Humans; Incidence; Infant, Newborn; Male; Neonatal Screening; Program Evaluation; Retrospective Studies | 2014 |
[Multicenter investigation on the impact of newborn infants' gestational age and birth weight on the level of 17α-hydroxyprogesterone].
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Female; Fluoroimmunoassay; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Neonatal Screening; Retrospective Studies; Sensitivity and Specificity | 2014 |
Measurement of Serum 17α-Hydroxyprogesterone in Infants by Radioimmunoassay.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Age Factors; Birth Weight; Early Diagnosis; Female; Gestational Age; Humans; Infant; Infant, Newborn; Male; Neonatal Screening; Radioimmunoassay; Reference Values; Sex Factors | 2015 |
Accurate prediction of gestational age using newborn screening analyte data.
Topics: 17-alpha-Hydroxyprogesterone; Algorithms; Amino Acids; Biomarkers; Biotinidase; Birth Weight; Carnitine; Cross-Sectional Studies; Fatty Acids; Female; Gestational Age; Humans; Infant, Newborn; Logistic Models; Male; Neonatal Screening; Ontario; Oxidation-Reduction; Pregnancy; Thyrotropin; UTP-Hexose-1-Phosphate Uridylyltransferase | 2016 |
Predicting gestational age using neonatal metabolic markers.
Topics: 17-alpha-Hydroxyprogesterone; Amino Acids; Biomarkers; Birth Weight; Carnitine; Fatty Acids; Female; Gestational Age; Humans; Infant, Newborn; Logistic Models; Male; Neonatal Screening; Pregnancy; Retrospective Studies; Thyrotropin; UTP-Hexose-1-Phosphate Uridylyltransferase | 2016 |
Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Gestational Age; Humans; Incidence; Infant, Newborn; Neonatal Screening; Predictive Value of Tests; Retrospective Studies; Tokyo | 2015 |
Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Age Factors; Birth Weight; Blood Specimen Collection; Chromatography, Liquid; False Positive Reactions; Fluoroimmunoassay; Humans; Infant, Newborn; Mass Spectrometry; Neonatal Screening; Reference Values | 2017 |
Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Birth Weight; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Reference Values; Treatment Outcome | 2008 |
Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Androgens; Androstenedione; Birth Weight; Body Mass Index; Body Size; Case-Control Studies; Estradiol; Female; Fetal Blood; Gestational Age; Humans; Infant, Newborn; Infant, Small for Gestational Age; Male; Maternal Age; Polycystic Ovary Syndrome; Reference Values; Weight Gain; Young Adult | 2010 |
Serum concentrations of adrenal steroids and their precursors as a measure of maturity of adrenocortical function in very premature newborns.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 3-Hydroxysteroid Dehydrogenases; Adrenal Cortex; Adrenal Cortex Function Tests; Adrenal Cortex Hormones; Adult; Apgar Score; Birth Weight; Chorioamnionitis; Cohort Studies; Cortodoxone; Dehydroepiandrosterone Sulfate; Female; Fetal Blood; Gestational Age; Humans; Hydrocortisone; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Pre-Eclampsia; Pregnancy; Prospective Studies | 2010 |
The effects of gestational age and birth weight on false-positive newborn-screening rates.
Topics: 17-alpha-Hydroxyprogesterone; Birth Weight; False Positive Reactions; Female; Gestational Age; Humans; Infant; Infant, Extremely Low Birth Weight; Infant, Low Birth Weight; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Neonatal Screening; Reference Values; Thyrotropin; Thyroxine | 2010 |
Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Brazil; False Positive Reactions; Female; Fluoroimmunoassay; Humans; Infant, Newborn; Male; Neonatal Screening; Predictive Value of Tests; Reference Values; Retrospective Studies; Statistics, Nonparametric | 2011 |
Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Dried Blood Spot Testing; False Positive Reactions; Humans; Hydrocortisone; Infant, Newborn; Neonatal Screening; Retrospective Studies; ROC Curve | 2012 |
Replication of clinical associations with 17-hydroxyprogesterone in preterm newborns.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; DNA; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Neonatal Screening; Prognosis; Prospective Studies; Respiratory Distress Syndrome, Newborn; Retrospective Studies | 2012 |
Precocious adrenarche in children born appropriate for gestational age: is there a difference between genders?
Topics: 17-alpha-Hydroxyprogesterone; Adrenarche; Androstenedione; Biomarkers; Birth Weight; Blood Glucose; Body Mass Index; Bone Development; Child; Child, Preschool; Cholesterol, HDL; Cohort Studies; Dehydroepiandrosterone Sulfate; Female; Gestational Age; Humans; Insulin; Male; Puberty; Puberty, Precocious; Sex Factors; Triglycerides | 2012 |
Clinical presentation of children with premature adrenarche.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Adrenal Hyperplasia, Congenital; Adrenarche; Age Determination by Skeleton; Birth Weight; Body Mass Index; Body Weight; Child; Child, Preschool; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Female; Humans; Male; Puberty, Precocious; Retrospective Studies | 2012 |
Maturity of the adrenal cortex in very preterm infants is related to gestational age.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenocorticotropic Hormone; Age Factors; Birth Weight; Cortisone; Female; Gestational Age; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Infant, Newborn; Infant, Premature; Male; Pituitary-Adrenal System | 2002 |
Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Aging; Birth Weight; False Negative Reactions; Germany; Humans; Incidence; Infant; Infant, Newborn; Neonatal Screening; Predictive Value of Tests; Sensitivity and Specificity | 2003 |
Effect of single and multiple courses of prenatal corticosteroids on 17-hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Apgar Score; Betamethasone; Birth Weight; Delivery, Obstetric; False Negative Reactions; Female; Humans; Infant, Newborn; Infant, Premature; Male; Neonatal Screening; Pregnancy; Prenatal Exposure Delayed Effects; Regression Analysis; Respiratory Distress Syndrome, Newborn; Sepsis | 2004 |
Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Gestational Age; Humans; Infant, Newborn; Neonatal Screening; Regression Analysis; Sensitivity and Specificity | 2005 |
Early puberty-menarche after precocious pubarche: relation to prenatal growth.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenarche; Adult; Age Factors; Birth Weight; Body Height; Child; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Longitudinal Studies; Menarche; Puberty; Puberty, Precocious; Sex Hormone-Binding Globulin | 2006 |
Newborn screening levels of 17-hydroxyprogesterone in very low birth weight infants and the relationship to chronic lung disease.
Topics: 17-alpha-Hydroxyprogesterone; Biomarkers; Birth Weight; Blood Pressure; Chronic Disease; Cohort Studies; Female; Gestational Age; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Lung Diseases; Male; Neonatal Screening; Oxygen; Oxygen Consumption; Pulmonary Alveoli; Respiration, Artificial; Respiratory Function Tests; Treatment Outcome | 2006 |
Endocrine-disrupting activities in vivo of the fungicides tebuconazole and epoxiconazole.
Topics: 17-alpha-Hydroxyprogesterone; Abnormalities, Drug-Induced; Animals; Birth Weight; Dose-Response Relationship, Drug; Endocrine Disruptors; Epoxy Compounds; Female; Fungicides, Industrial; Genitalia, Female; Lactation; Male; Maternal Exposure; Nipples; Organ Size; Pregnancy; Progesterone; Rats; Rats, Wistar; Reproduction; Sperm Count; Sperm Motility; Spermatozoa; Testis; Testosterone; Triazoles | 2007 |
Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Androstenedione; Birth Weight; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Fetal Growth Retardation; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Infant, Newborn; Insulin; Luteinizing Hormone; Organ Size; Polycystic Ovary Syndrome; Prospective Studies; Regression Analysis; Retrospective Studies; Testosterone | 2008 |
Neonatal screening for congenital adrenal hyperplasia.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Italy; Male; Mass Screening; Time Factors | 1983 |
Plasma 17-hydroxyprogesterone concentrations in ill newborn infants.
Topics: 17-alpha-Hydroxyprogesterone; Birth Weight; Gestational Age; Humans; Hydroxyprogesterones; Infant, Low Birth Weight; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature, Diseases | 1983 |
Anovulation after precocious pubarche: early markers and time course in adolescence.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenocorticotropic Hormone; Anovulation; Birth Weight; Child; Female; Hair; Humans; Menarche; Ovulation; Puberty, Precocious | 1999 |
Longitudinal measurements of 17alpha-hydroxyprogesterone in premature infants during the first three months of life.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Analysis of Variance; Biomarkers; Birth Weight; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Male; Respiratory Distress Syndrome, Newborn; Steroids | 1999 |
[Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Biomarkers; Birth Weight; Chile; Cost-Benefit Analysis; Gestational Age; Humans; Infant, Newborn; Mass Screening; Radioimmunoassay; Reference Values | 2000 |
Neonatal screening program for congenital adrenal hyperplasia: adjustments to the recall protocol.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Male; Mass Screening; Pilot Projects; Sodium Chloride; Virilism | 2001 |
Fetal growth and the function of the adrenal cortex in preterm infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex; Adrenocorticotropic Hormone; Birth Weight; Cortisone; Embryonic and Fetal Development; Fetus; Humans; Hydrocortisone; Infant, Newborn; Infant, Premature | 2002 |
Serum adrenal steroid concentrations in premature infants.
Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; 18-Hydroxycorticosterone; Aldosterone; Androstenedione; Birth Weight; Cortodoxone; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Gestational Age; Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Male; Steroids | 1989 |
Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in neonates.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Aging; Biomarkers; Birth Weight; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Random Allocation; Reference Values | 1988 |
Adrenal status during the first month of life in mature and premature human infants.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Glands; Aging; Birth Weight; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Infant, Premature; Steroids | 1987 |
Neonatal screening program for congenital adrenal hyperplasia in a homogeneous Caucasian population.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Birth Weight; Female; Gestational Age; Humans; Hydroxyprogesterones; Infant, Newborn; Italy; Male; Mass Screening; Steroid Hydroxylases | 1985 |